| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syros Pharmaceuticals, Inc. (SYRS) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. SYRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | Olson Eric R | Chief Scientific Officer | Sale+OE | 3,628 | $9.47 | $34,371.67 | -100% | |
| Feb 16, 2021 | Young Richard A | Director | Sell | 3,750 | $12.05 | $45,187.50 | -1.2% | |
| Feb 8, 2021 | Young Richard A | Director | Sell | 3,750 | $13.04 | $48,900.00 | -1.1% | |
| Nov 17, 2020 | Young Richard A | Director | Sell | 5,990 | $8.77 | $52,558.09 | -0.9% | |
| Oct 19, 2020 | Young Richard A | Director | Sell | 5,673 | $8.75 | $49,638.75 | -1.7% | |
| Oct 15, 2020 | Young Richard A | Director | Sell | 317 | $8.75 | $2,773.75 | - | |
| Sep 15, 2020 | Young Richard A | Director | Sell | 5,990 | $10.39 | $62,236.10 | -1.7% | |
| Aug 18, 2020 | Olson Eric R | Chief Scientific Officer | Sale+OE | 15,750 | $13.00 | $204,750.00 | -100% | |
| Aug 18, 2020 | Akkaraju Srinivas81 | Director | Sell | 159,327 | $13.10 | $2,086,395.68 | -5.6% | |
| Aug 17, 2020 | Young Richard A | Director | Sell | 5,990 | $12.59 | $75,414.10 | -1.7% |